Previous close | 66.74 |
Open | 67.05 |
Bid | 66.62 x 900 |
Ask | 66.63 x 900 |
Day's range | 66.33 - 67.36 |
52-week range | 53.63 - 71.70 |
Volume | |
Avg. volume | 6,314,388 |
Market cap | 206.594B |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.36 |
Earnings date | N/A |
Forward dividend & yield | 1.45 (2.18%) |
Ex-dividend date | 11 Aug 2022 |
1y target est | 73.38 |
Merck (MRK) is set to make an upfront payment of $150 million to Orna for rights to the latter's circular RNA technology to make vaccines and therapeutics for infectious disease and oncology.
Pharma group alleges breach of non-compete agreement to delay start date of departing business development official
FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) Lynparza as a combination therapy for patients with metastatic castration-resistant prostate cancer.